A predictive algorithm presented at AMP 2025 may extend the Guidance UTI workflow by delivering actionable insights before full susceptibility results are available.
Neuroimaging detects reduced grey matter in multiple brain regions among breast cancer patients after chemotherapy, raising concern for long-term cognitive risks.